Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron for Treatment of Anaemia before Cardiac Surgery
2016-004439-19Phase 4Unknown
- Sponsor
- Alfred Health
- Start
- Apr 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of ferric derisomaltose in anaemia and iron deficiency anemia (IDA), sponsored by Alfred Health. Primary endpoint: Days alive and out of hospital (DAOH) from surgery to 30 days following operation. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
anaemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on 2016-004439-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004439-19.